Vimarsana
Biggest News Aggregation in the World

Ridgeback Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ridgeback Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ridgeback Capital Today - Breaking & Trending Today

Grossman alum donates $15 million in research funding to NYU Langone - Vimarsana News

Grossman alum donates $15 million in research funding to NYU Langone

NYU Langone Health received $15 million from philanthropists Wendy and Wayne Holman earlier this month, marking the largest gift ever given to the NYU Grossman School of Medicine by one of its alumni. The contribution will be put toward expanding research in endocrinology, diabetes and metabolism.  Wayne said the donation aims to enhance support for...

Billionaire Leonard Lauder Gives $52 Million for Nurse-Practitioner Program - Vimarsana News

Billionaire Leonard Lauder Gives $52 Million for Nurse-Practitioner Program

Plus, McKenzie Scott gave $15 million to support Lutheran Immigration and Refugee Service, and three universities and the MD Anderson Cancer Center all landed big gifts.

Crisp Raises $35M for its Data Connectivity and Insights Platform for the Retail Industry - Vimarsana News

Crisp Raises $35M for its Data Connectivity and Insights Platform for the Retail Industry

Crisp, founded by Are Traasdahl, is a retail data connectivity platform that provides unprecedented visbility into the supply chain

Crisp Raises $35M in Series B to Accelerate Growth as Adoption of Supply Chain Data and Optimization Technology Skyrockets - Vimarsana News

Crisp Raises $35M in Series B to Accelerate Growth as Adoption of Supply Chain Data and Optimization Technology Skyrockets

Food industry news, voices and jobs. Optimized for your mobile phone.

Quell Therapeutics Secures Significant Series B Financing To Enhance Future Clinical Development And Manufacturing - Vimarsana News

Quell Therapeutics Secures Significant Series B Financing To Enhance Future Clinical Development And Manufacturing

Quell Therapeutics Ltd ("Quell"), the world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical...